Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Fam Cancer. 2011 Jun;10(2):213–223. doi: 10.1007/s10689-011-9425-2

Table 2.

Impact of BRCA1/2 test result on distress outcomes in men

Variable 6-Month outcomes Z scores
12-Month outcomes Z scores
Cancer-specific distress General distress Genetic-testing distress Cancer-specific distress General distress Genetic-testing distress
Associated baseline variablea 2.76** 4.97*** 1.13 5.59*** 3.92*** 2.64**
Age −2.96*** −1.56 −0.53 −2.08* −1.97* −0.51
# Daughters ≤ 18 years −0.10 −0.66 −0.13 0.62 −0.38 0.60
Jewish ethnicity (vs. not) 0.91 1.69b 0.17 1.72b 0.41 −0.06
Employed full-time (vs. not) −2.31* 1.15 1.05 −1.37 0.18 −0.86
Annual income ≥ $75,000 (vs. not) 1.02 0.55 2.19* 0.21 1.04 2.25*
Study site (GU vs. NY/NJ) 0.79 1.27 −0.95 0.69 1.50 0.49
BRCA1/2 carrier (vs. non-carrier) −0.95 1.03 4.48*** 0.62 −0.15 2.78**
a

We included the baseline variable associated with the specified outcome within the general estimating equation models. For genetic testing distress, we used cancer-specific distress at baseline, as we did not have a baseline measure of genetic testing distress

b

P < 0.10

*

P < 0.05;

**

P < 0.01;

***

P < 0.001